Advertisement
Advertisement

QDEL

QDEL logo

QuidelOrtho Corporation Common Stock

15.94
USD
Sponsored
-0.23
-1.42%
Mar 25, 12:33 UTC -4
Open

QDEL Earnings Reports

Positive Surprise Ratio

QDEL beat 29 of 40 last estimates.

73%

Next Report

Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$694.20M
/
$0.45
Implied change from Q4 25 (Revenue/ EPS)
-4.06%
/
-2.17%
Implied change from Q1 25 (Revenue/ EPS)
+0.20%
/
-39.19%

QuidelOrtho Corporation Common Stock earnings per share and revenue

On Feb 11, 2026, QDEL reported earnings of 0.46 USD per share (EPS) for Q4 25, beating the estimate of 0.43 USD, resulting in a 6.58% surprise. Revenue reached 723.60 million, compared to an expected 722.59 million, with a 0.14% difference. The market reacted with a -17.59% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 9 analysts forecast an EPS of 0.45 USD, with revenue projected to reach 694.20 million USD, implying an decrease of -2.17% EPS, and decrease of -4.06% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
logo
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
logo
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.26
Surprise
+98.02%
logo
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
logo
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
logo
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
logo
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
logo
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
For Q4 2025, QuidelOrtho Corporation Common Stock reported EPS of $0.46, beating estimates by 6.58%, and revenue of $723.60M, 0.14% above expectations.
The stock price moved down -17.59%, changed from $28.80 before the earnings release to $23.73 the day after.
The next earning report is scheduled for May 05, 2026.
Based on 9 analysts, QuidelOrtho Corporation Common Stock is expected to report EPS of $0.45 and revenue of $694.20M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement